Medicine
Chlorzoxazone 500 mg tablet
Chlorzoxazone 500 mg tablet is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25° C (68° to 77° F).
Key facts
- Active ingredient (INN)
- Chlorzoxazone
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 20 tablets and 92 more
- Manufacturers
- Aurobindo PharmaIndiaBryant Ranch PrepackActavis PharmaCintex ServicesNovitium PharmaRising Pharma HoldingsMayne Pharma Commercial14 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25° C (68° to 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03BB03 Chlorzoxazone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 August 2011
- Identifiers
- RxCUI 197502, 1088934, 1088936DailyMed set ID 267a0a2a-b818-47d9-9b61-28be172de99a, a21c6113-cf80-4bdd-bfe5-8cfd02f107fc, 6c418b8f-4a1c-4611-80d5-3a3a7dbca9c8 +17NDC 71335-1914, 85766-283, 50090-0315 +17Application ANDA212254, ANDA089853, ANDA089859 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 14 labelers. The register lists 95 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59651-306-01 | Aurobindo PharmaIndia | 3 August 2020 |
| 500 tablet in 1 bottle | 59651-306-05 | Aurobindo PharmaIndia | 3 August 2020 |
| 100 tablet in 1 bottle, plastic | 0591-2520-01 | Actavis Pharma | 22 August 2011 |
| 500 tablet in 1 bottle, plastic | 0591-2520-05 | Actavis Pharma | 22 August 2011 |
| 100 tablet in 1 bottle | 24470-940-10 | Cintex Services | 21 March 2024 |
| 500 tablet in 1 bottle | 24470-940-50 | Cintex Services | 21 March 2024 |
| 100 tablet in 1 bottle | 51862-339-01 | Mayne Pharma Commercial | 31 July 2020 |
| 100 tablet in 1 bottle | 70954-085-10 | Novitium Pharma | 12 September 2019 |
| 500 tablet in 1 bottle | 70954-085-20 | Novitium Pharma | 12 September 2019 |
| 100 tablet in 1 bottle | 16571-726-01 | Rising Pharma Holdings | 5 April 2022 |
| 500 tablet in 1 bottle | 16571-726-50 | Rising Pharma Holdings | 28 April 2023 |
| 20 tablet in 1 bottle | 63629-1586-1 | Bryant Ranch Prepack | 8 October 2024 |
| 30 tablet in 1 bottle | 63629-1586-2 | Bryant Ranch Prepack | 8 October 2024 |
| 40 tablet in 1 bottle | 63629-1586-3 | Bryant Ranch Prepack | 22 October 2012 |
| 90 tablet in 1 bottle | 63629-1586-4 | Bryant Ranch Prepack | 8 October 2024 |
| 60 tablet in 1 bottle | 63629-1586-5 | Bryant Ranch Prepack | 8 October 2024 |
| 100 tablet in 1 bottle | 63629-1586-6 | Bryant Ranch Prepack | 8 October 2024 |
| 14 tablet in 1 bottle | 63629-1586-7 | Bryant Ranch Prepack | 8 October 2024 |
| 7 tablet in 1 bottle | 63629-1586-8 | Bryant Ranch Prepack | 8 October 2024 |
| 120 tablet in 1 bottle | 63629-1586-9 | Bryant Ranch Prepack | 18 July 2012 |
| 20 tablet in 1 bottle | 71335-1914-1 | Bryant Ranch Prepack | 25 October 2021 |
| 30 tablet in 1 bottle | 71335-1914-2 | Bryant Ranch Prepack | 10 August 2021 |
| 40 tablet in 1 bottle | 71335-1914-3 | Bryant Ranch Prepack | 25 October 2021 |
| 90 tablet in 1 bottle | 71335-1914-4 | Bryant Ranch Prepack | 14 July 2021 |
| 60 tablet in 1 bottle | 71335-1914-5 | Bryant Ranch Prepack | 16 September 2021 |
| 100 tablet in 1 bottle | 71335-1914-6 | Bryant Ranch Prepack | 25 October 2021 |
| 14 tablet in 1 bottle | 71335-1914-7 | Bryant Ranch Prepack | 25 October 2021 |
| 7 tablet in 1 bottle | 71335-1914-8 | Bryant Ranch Prepack | 25 October 2021 |
| 120 tablet in 1 bottle | 71335-1914-9 | Bryant Ranch Prepack | 25 October 2021 |
| 20 tablet in 1 bottle | 71335-2009-1 | Bryant Ranch Prepack | 3 April 2024 |
| 30 tablet in 1 bottle | 71335-2009-2 | Bryant Ranch Prepack | 3 April 2024 |
| 40 tablet in 1 bottle | 71335-2009-3 | Bryant Ranch Prepack | 3 April 2024 |
| 90 tablet in 1 bottle | 71335-2009-4 | Bryant Ranch Prepack | 3 December 2021 |
| 60 tablet in 1 bottle | 71335-2009-5 | Bryant Ranch Prepack | 22 December 2022 |
| 100 tablet in 1 bottle | 71335-2009-6 | Bryant Ranch Prepack | 3 April 2024 |
| 14 tablet in 1 bottle | 71335-2009-7 | Bryant Ranch Prepack | 3 April 2024 |
| 7 tablet in 1 bottle | 71335-2009-8 | Bryant Ranch Prepack | 3 April 2024 |
| 120 tablet in 1 bottle | 71335-2009-9 | Bryant Ranch Prepack | 3 April 2024 |
| 20 tablet in 1 bottle | 71335-2433-1 | Bryant Ranch Prepack | 9 September 2024 |
| 30 tablet in 1 bottle | 71335-2433-2 | Bryant Ranch Prepack | 9 September 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 August 1958 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Chlorzoxazone
Clinical summary
Chlorzoxazone is a muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is available as tablets for oral use. MedsAcross supplies Chlorzoxazone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChlorzoxazoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- chlorzoxazone prescribing information (Solubiomix) · U.S. National Library of Medicine, DailyMed
Need Chlorzoxazone 500 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.